Identification and Management of Cardiometabolic Risk after Spinal Cord Injury

References

• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499–502.
   PubMed Web of Science ®Google Scholar
• Groah SL, Nash MS, Ward EA, Libin A, Mendez AJ, Burns P, et al. Cardiometabolic risk in community-dwelling persons with chronic spinal cord injury. J Cardiopulm Rehabil Prev 2011;31(2):73–80.
   PubMed Web of Science ®Google Scholar
• Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004;44(1):6–11.
   PubMed Web of Science ®Google Scholar
• Tracy RP. Inflammation, the metabolic syndrome and cardiovascular risk. Int J Clin Pract Suppl 2003(134):10–17.
   PubMedGoogle Scholar
• Liang H, Chen D, Wang Y, Rimmer JH, Braunschweig CL. Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates. Arch Phys Med Rehabil 2007;88(9):1198–204.
   PubMed Web of Science ®Google Scholar
• Libin A, Tinsley E, Nash M, Mendez A, Burns P, Elrod M, et al. Cardiometabolic risk clustering in spinal cord injury: results of exploratory factor analysis. Top Spinal Cord Inj Rehabil 2013;19(3):183–94.
   PubMedGoogle Scholar
• Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol 2004;44(3):720–32.
   PubMedGoogle Scholar
• Bray GA, Champagne CM. Beyond energy balance: there is more to obesity than kilocalories. J Am Diet Assoc 2005;105(5):17–23.
   Google Scholar
• Obesity. Preventing and managing the global epidemic. report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:1–253.
   Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A consensus statement from the international diabetes federation. Diabetic Med 2006;23(5):469–80.
   PubMed Web of Science ®Google Scholar
• Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009;120(16):1640–45.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB, Jr., Cleeman JI, et al. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation 2004;109(3):433–38.
   PubMed Web of Science ®Google Scholar
• Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28(7):1769–78.
   PubMed Web of Science ®Google Scholar
• Ford ES, Abbasi F, Reaven GM. Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose. Atherosclerosis 2005;181(1):143–8.
   PubMed Web of Science ®Google Scholar
• Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the US. Diabetes Care 2005;28(11):2745–49.
   PubMed Web of Science ®Google Scholar
• Wahman K, Nash MS, Westgren N, Lewis JE, Seiger A, Levi R. Cardiovascular disease risk factors in persons with paraplegia: the Stockholm spinal cord injury study. J Rehabil Med 2010;42(3):272–8.
   PubMed Web of Science ®Google Scholar
• Spungen AM, Wang J, Pierson RN, Bauman WA. Soft tissue body composition differences in monozygotic twins discordant for spinal cord injury. J Appl Physiol 2000;88(4):1310–15.
   PubMed Web of Science ®Google Scholar
• Yarar-Fisher C, Chen Y, Jackson AB, Hunter GR. Body mass index underestimates adiposity in women with spinal cord injury. Obesity 2013;21(6):1223–25.
   PubMed Web of Science ®Google Scholar
• Beck LA, Lamb JL, Atkinson EJ, Wuermser L-A, Amin S. Body composition of women and men with complete motor paraplegia. J Spinal Cord Med 2014;37(4):359–65.
   PubMed Web of Science ®Google Scholar
• Buchholz AC, McGillivray CF, Pencharz PB. The use of bioelectric impedance analysis to measure fluid compartments in subjects with chronic paraplegia. Arch Phys Med Rehabil 2003;84(6):854–61.
   PubMed Web of Science ®Google Scholar
• Cirnigliaro CM, LaFountaine MF, Dengel DR, Bosch TA, Emmons RR, Kirshblum SC, et al. Visceral adiposity in persons with chronic spinal cord injury determined by dual energy X-Ray absorptiometry. Obesity 2015;23(9):1811–17.
   PubMed Web of Science ®Google Scholar
• Clasey JL, Gater DR. A comparison of hydrostatic weighing and air displacement plethysmography in adults with spinal cord injury. Arch Phys Med Rehabil 2005;86(11):2106–13.
   PubMed Web of Science ®Google Scholar
• Gorgey AS, Gater DR. Regional and relative adiposity patterns in relation to carbohydrate and lipid metabolism in men with spinal cord injury. Appl Physiol Nutr Metab 2011;36(1):107–14.
   PubMed Web of Science ®Google Scholar
• Gorgey AS, Mather KJ, Poarch HJ, Gater DR. Influence of motor complete spinal cord injury on visceral and subcutaneous adipose tissue measured by multi-axial magnetic resonance imaging. J Spinal Cord Med 2011;34(1):99–109.
   PubMed Web of Science ®Google Scholar
• Gater DR, Farkas GJ. Alterations in body composition after SCI and the mitigating role of exercise. The Physiology of Exercise in Spinal Cord Injury: Springer 2016;28(9):175–98.
   Google Scholar
• Lavela SL, Weaver FM, Goldstein B, Chen K, Miskevics S, Rajan S, et al. Diabetes mellitus in individuals with spinal cord injury or disorder. J Spinal Cord Med 2006;29(4):387–95.
   PubMed Web of Science ®Google Scholar
• LaVela SL, Evans CT, Prohaska TR, Miskevics S, Ganesh SP, Weaver FM. Males aging with a spinal cord injury: prevalence of cardiovascular and metabolic conditions. Arch Phys Med Rehabil 2012;93(1):90–5.
   PubMed Web of Science ®Google Scholar
• Rajan S, McNeely MJ, Hammond M, Goldstein B, Weaver F. Association between obesity and diabetes mellitus in veterans with spinal cord injuries and disorders. Am J Phys Med Rehabil/Association of Academic Physiatrists 2010;89(5):353–61.
   PubMed Web of Science ®Google Scholar
• Wahman K, Nash MS, Lewis JE, Seiger A, Levi R. Increased cardiovascular disease risk in Swedish persons with paraplegia: The Stockholm spinal cord injury study. J Rehabil Med 2010;42(5):489–92.
   PubMed Web of Science ®Google Scholar
• Cragg JJ, Noonan VK, Dvorak M, Krassioukov A, Mancini GB, Borisoff JF. Spinal cord injury and type 2 diabetes: results from a population health survey. Neurology 2013;81(21):1864–68.
   PubMed Web of Science ®Google Scholar
• Chung W-S, Lin C-L, Chang S-N, Chung H-A, Sung F-C, Kao C-H. Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with spinal cord injury: a nationwide cohort prospective study. Thromb Res 2014;133(4):579–84.
   PubMed Web of Science ®Google Scholar
• Imai K, Kadowaki T, Aizawa Y, Fukutomi K. Problems in the health management of persons with spinal cord injury. J Clin Epidemiol 1996;49(5):505–10.
   PubMed Web of Science ®Google Scholar
• Gorgey AS, Dolbow DR, Dolbow JD, Khalil RK, Castillo C, Gater DR. Effects of spinal cord injury on body composition and metabolic profile–part I. J Spinal Cord Med 2014;37(6):693–702.
   PubMed Web of Science ®Google Scholar
• Myers J, Lee M, Kiratli J. Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management. Am J Phys Med Rehabil 2007;86(2):142–52.
   PubMed Web of Science ®Google Scholar
• Bauman W, Kahn N, Grimm D, Spungen A. Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury. Spinal Cord 1999;37(9):601–16.
   PubMed Web of Science ®Google Scholar
• Gilbert O, Croffoot JR, Taylor AJ, Nash M, Schomer K, Groah S. Serum lipid concentrations among persons with spinal cord injury – A systematic review and meta-analysis of the literature. Atherosclerosis 2014;232(2):305–12.
   PubMed Web of Science ®Google Scholar
• Bauman W, Adkins R, Spungen A, Herbert R, Schechter C, Smith D, et al. Is immobilization associated with an abnormal lipoprotein profile? observations from a diverse cohort. Spinal Cord 1999;37(7):485–93.
   PubMed Web of Science ®Google Scholar
• Washburn R, Figoni S. High density lipoprotein cholesterol in individuals with spinal cord injury: the potential role of physical activity. Spinal Cord 1999;37(10):685–95.
   PubMed Web of Science ®Google Scholar
• Nash MS, Mendez AJ. A guideline-driven assessment of need for cardiovascular disease risk intervention in persons with chronic paraplegia. Arch Phys Med Rehabil 2007;88(6):751–57.
   PubMed Web of Science ®Google Scholar
• Zlotolow SP, Levy E, Bauman WA. The serum lipoprotein profile in veterans with paraplegia: the relationship to nutritional factors and body mass index. J Am Paraplegia Soc 1992;15(3):158–62.
   PubMedGoogle Scholar
• Bauman WA, Spungen AM, Zhong Y-G, Rothstein JL, Petry C, Gordon SK. Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury. Spinal Cord 1992;30(10):697–703.
   Web of Science ®Google Scholar
• Krum H, Howes L, Brown DJ, Ungar G, Moore P, McNeil JJ, et al. Risk factors for cardiovascular disease in chronic spinal cord injury patients. Spinal Cord 1992;30(6):381–88.
   Web of Science ®Google Scholar
• Lieberman J, Goff D, Hammond F, Schreiner P, Norton H, Dulin M, et al. Dietary intake relative to cardiovascular disease risk factors in individuals with chronic spinal cord injury: a pilot study. Top Spinal Cord Inj Rehabil 2014;20(2):127–36.
   PubMedGoogle Scholar
• Tóth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: the national health and nutrition examination survey 2003–2006. J Clin Lipidol 2012;6(4):325–30.
   PubMed Web of Science ®Google Scholar
• Barry W, St Andre J, Evans C, Sabharwal S, Miskevics S, Weaver FM, et al. Hypertension and antihypertensive treatment in veterans with spinal cord injury and disorders. Spinal Cord 2013;51(2):109–15.
   PubMed Web of Science ®Google Scholar
• Zhu C, Galea M, Livote E, Signor D, Wecht JM. A retrospective chart review of heart rate and blood pressure abnormalities in veterans with spinal cord injury. J Spinal Cord Med 2013;36(5):463–75.
   PubMed Web of Science ®Google Scholar
• Wecht JM, Zhu C, Weir JP, Yen C, Renzi C, Galea M. A prospective report on the prevalence of heart rate and blood pressure abnormalities in veterans with spinal cord injuries. J Spinal Cord Med 2013;36(5):454–62.
   PubMed Web of Science ®Google Scholar
• Weaver FM, Collins EG, Kurichi J, Miskevics S, Smith B, Rajan S, et al. Prevalence of obesity and high blood pressure in veterans with spinal cord injuries and disorders - A retrospective review. AmJ Phys Med Rehabil 2007;86(1):22–9.
   PubMed Web of Science ®Google Scholar
• Hitzig SL, Tonack M, Campbell KA, McGillivray CF, Boschen KA, Richards K, et al. Secondary health complications in an aging Canadian spinal cord injury sample. Am J Phys Med Rehabil 2008;87(7):545–55.
   PubMed Web of Science ®Google Scholar
• Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee I-M, et al. American college of sports medicine position stand. quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sport Exer 2011;43(7):1334–59.
   PubMed Web of Science ®Google Scholar
• Thompson WR, Gordon NF, Pescatello LS. ACSM’s Guidelines for Exercise Testing and Prescription. 9th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2010.
   Google Scholar
• Ginis KA, Hicks AL, Latimer AE, Warburton DER, Bourne C, Ditor DS, et al. The development of evidence-informed physical activity guidelines for adults with spinal cord injury. Spinal Cord 2011;49(11):1088–96.
   PubMed Web of Science ®Google Scholar
• Association APT. Physical Fitness for Individuals with Spinal Cord Injury. Alexandria, VA: American Physical Therapy Association.; 2015.
   Google Scholar
• Dearwater SR, LaPorte RE, Robertson RJ, Brenes G, Adams LL, Becker D. Activity in the spinal cord-injured patient: an epidemiologic analysis of metabolic parameters. Med Sci Sports Exerc 1986;18(5):541–44.
   PubMed Web of Science ®Google Scholar
• Noreau L, Shephard RJ, Simard C, Pare G, Pomerleau P. Relationship of impairment and functional ability to habitual activity and fitness following spinal cord injury. Int J Rehabil Res 1993;16(4):265–76.
   PubMedGoogle Scholar
• Ginis KA, Latimer AE, Arbour-Nicitopoulos KP, Buchholz AC, Bray SR, Craven BC, et al. Leisure time physical activity in a population-based sample of people with spinal cord injury part I: demographic and injury-related correlates. Arch Phys Med Rehabil 2010;91(5):722–28.
   PubMed Web of Science ®Google Scholar
• Miller LE, Herbert WG. Health and economic benefits of physical activity for patients with spinal cord injury. Clinicoecon Outcomes Res 2016;8:551–58.
   PubMed Web of Science ®Google Scholar
• Simmons OL, Kressler J, Nash MS. Reference fitness values in the untrained spinal cord injury population. Arch Phys Med Rehabil 2014;95(12):2272–78.
   PubMed Web of Science ®Google Scholar
• Bostom AG, Toner MM, McArdle WD, Montelione T, Brown CD, Stein RA. Lipid and lipoprotein profiles relate to peak aerobic power in spinal cord injured men. Med Sci Sports Exerc 1991;23(4):409–14.
   PubMed Web of Science ®Google Scholar
• Brenes G, Dearwater S, Shapera R, LaPorte RE, Collins E. High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil 1986;67(7):445–50.
   PubMed Web of Science ®Google Scholar
• LaPorte RE, Adams LL, Savage DD, Brenes G, Dearwater S, Cook T. The spectrum of physical activity, cardiovascular disease and health: an epidemiologic perspective. Am J Epidemiol 1984;120(4):507–17.
   PubMed Web of Science ®Google Scholar
• LaPorte RE, Brenes G, Dearwater S, Ann Murphy M, Cauley JA, Dietrick R, et al. HDL cholesterol across a spectrum of physical activity from quadriplegia to marathon running. Lancet 1983;321(8335):1212–13.
   Google Scholar
• Halle M, Berg A, Baumstark M, Keul J. Association of physical fitness with LDL and HDL subfractions in young healthy men. Int J Sports Med 1999;20(7):464–69.
   PubMed Web of Science ®Google Scholar
• Franks PW, Ekelund U, Brage S, Wong M-Y, Wareham NJ. Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness? Diabetes Care 2004;27(5):1187–93.
   PubMed Web of Science ®Google Scholar
• Carnethon MR, Gulati M, Greenland P. Prevalence and cardiovascular disease correlates of low cardiorespiratory fitness in adolescents and adults. J Am Med Assoc 2005;294(23):2981–88.
   PubMed Web of Science ®Google Scholar
• Cowan RE, Nash MS, Anderson KD. Exercise participation barrier prevalence and association with exercise participation status in individuals with spinal cord injury. Spinal Cord 2013;51(1):27–32.
   PubMed Web of Science ®Google Scholar
• Scelza WM, Kalpakjian CZ, Zemper ED, Tate DG. Perceived barriers to exercise in people with spinal cord injury. Am J Phys Med Rehabil 2005;84(8):576–83.
   PubMed Web of Science ®Google Scholar
• Vissers M, van den Berg-Emons R, Sluis T, Bergen M, Stam H, Bussmann H. Barriers to and facilitators of everyday physical activity in persons with a spinal cord injury after discharge from the rehabilitation centre. J Rehabil Med 2008;40(6):461–67.
   PubMed Web of Science ®Google Scholar
• Cowan RE, Nash MS, Anderson KD. Exercise participation barrier prevalence and association with exercise participation status in individuals with spinal cord injury. Spinal Cord 2012;18(2):126–27.
   Google Scholar
• Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 2003;107(3):499–511.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342(12):836–43.
   PubMed Web of Science ®Google Scholar
• Cragg JJ, Stone JA, Krassioukov AV. Management of cardiovascular disease risk factors in individuals with chronic spinal cord injury: an evidence-based review. J Neurotraum 2012;29(11):1999–2012.
   PubMed Web of Science ®Google Scholar
• Lee M, Myers J, Hayes A, Madan S, Froelicher VF, Perkash I, et al. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury. J Spinal Cord Med 2005;28(1):20–5.
   PubMed Web of Science ®Google Scholar
• Wang TD, Wang YH, Huang TS, Su TC, Pan SL, Chen SY. Circulating levels of markers of inflammation and endothelial activation are increased in men with chronic spinal cord injury. J Formos Med Assoc 2007;106(11):919–28.
   PubMed Web of Science ®Google Scholar
• Frost F, Roach MJ, Kushner I, Schreiber P. Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch Phys Med Rehabil 2005;86(2):312–17.
   PubMed Web of Science ®Google Scholar
• Davies AL, Hayes KC, Dekaban GA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil 2007;88(11):1384–93.
   PubMed Web of Science ®Google Scholar
• Gibson A, Buchholz A, Ginis KM. C-Reactive protein in adults with chronic spinal cord injury: increased chronic inflammation in tetraplegia vs paraplegia. Spinal Cord 2008;46(9):616–21.
   PubMed Web of Science ®Google Scholar
• Maggioni M, Bertoli S, Margonato V, Merati G, Veicsteinas A, Testolin G. Body composition assessment in spinal cord injury subjects. Acta Diabetol 2003;40:S183–S186.
   PubMed Web of Science ®Google Scholar
• Maruyama Y, Mizuguchi M, Yaginuma T, Kusaka M, Yoshida H, Yokoyama K, et al. Serum leptin, abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injury. Spinal Cord 2008;46(7):494–99.
   PubMed Web of Science ®Google Scholar
• Spungen AM, Adkins RH, Stewart CA, Wang J, Pierson RN, Waters RL, et al. Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol 2003;95(6):2398–407.
   PubMed Web of Science ®Google Scholar
• Chen YY, Cao Y, Allen V, Richards JS. Weight matters: physical and psychosocial well being of persons with spinal cord injury in relation to body mass index. Arch Phys Med Rehabil 2011;92(3):391–98.
   PubMed Web of Science ®Google Scholar
• Liang HF, Chen D, Braunschweig CL. Elevated C-reactive protein and better insulin sensitivity in men with spinal cord injury compared to able- bodied men. Diabetes 2007;56:A246–A246.
   Web of Science ®Google Scholar
• Marathe PH, Gao HX, Close KL. American diabetes association standards of medical care in diabetes. J Diabetes 2017;9:320–324.
   Google Scholar
• Bauman WA, Spungen AM. Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal Cord Med 2001;24(4):266–77.
   PubMedGoogle Scholar
• Gorgey AS. Exercise awareness and barriers after spinal cord injury. World J Orthop 2014;5(3):158–62.
   PubMedGoogle Scholar
• Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research. Circulation 2005;111(5):697–716.
   PubMed Web of Science ®Google Scholar
• Mathias CJ. Orthostatic hypotension and paroxysmal hypertension in humans with high spinal cord injury. Prog Brain Res 2006;152:231–43.
   PubMed Web of Science ®Google Scholar
• Linsenmeyer TA, Baker ER, Cardenas DD, Mobley T, Perkash I, Vogel LC. Consortium for spinal cord medicine. Acute management of autonomic dysreflexia: individuals with spinal cord injury presenting to health-care facilities. J Spinal Cord Med 2001; 25(Suppl 1):S67–88.
   Google Scholar
• Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American association of clinical endocrinologists and American college of endocrinology guidelines for management of dysplipidemia and prevention of cardiovasuclar disease. Endocr Pract 2017;23(s2):1–87.
   PubMed Web of Science ®Google Scholar
• Nash MS, Tractenberg RE, Mendez AJ, David M, Ljungberg IH, Tinsley EA, et al. Cardiometabolic syndrome in people with spinal cord injury/disease: guideline-derived and non- guideline risk components in a pooled sample. Arch Phys Med Rehabil 2016;97(10):1696–705.
   PubMed Web of Science ®Google Scholar
• Arya R, Lehman D, Hunt KJ, Schneider J, Almasy L, Blangero J, et al. Evidence for bivariate linkage of obesity and HDL-C levels in the framingham heart study. BMC Genetics 2003;4(Suppl 1):S52.
   PubMed Web of Science ®Google Scholar
• Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of U.S. adults. Am J Epidemiol 1997;146(3):214–22.
   PubMed Web of Science ®Google Scholar
• Resnick HE, Valsania P, Halter JB, Lin X. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 2000;54(8):596–602.
   PubMed Web of Science ®Google Scholar
• Barter PJ. Management of low HDL cholesterol. Aust Fam Physician 1995;24(11):2066–69.
   PubMedGoogle Scholar
• Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. New Engl J Med 2007;357(13):1301–10.
   PubMed Web of Science ®Google Scholar
• Modlesky CM, Bickel CS, Slade JM, Meyer RA, Cureton KJ, Dudley GA. Assessment of skeletal muscle mass in men with spinal cord injury using dual-energy X-ray absorptiometry and magnetic resonance imaging. J Appl Physiol 2004;96(2):561–65.
   PubMed Web of Science ®Google Scholar
• Jones L, Goulding A, Gerrard D. DEXA: a practical and accurate tool to demonstrate total and regional bone loss, lean tissue loss and fat mass gain in paraplegia. Spinal Cord 1998;36(9):637–40.
   PubMed Web of Science ®Google Scholar
• Nuhlicek D, Spurr G, Barboriak J, Rooney C, El Ghatit A, Bongard R. Body composition of patients with spinal cord injury. Eur J Clin Nutr 1988;42(9):765–73.
   PubMed Web of Science ®Google Scholar
• Castro MJ, Apple DF, Hillegass EA, Dudley GA. Influence of complete spinal cord injury on skeletal muscle cross-sectional area within the first 6 months of injury. Eur J Appl Physiol Occup Physiol 1999;80(4):373–78.
   PubMed Web of Science ®Google Scholar
• Stjernberg L, Blumberg H, Wallin BG. Sympathetic activity in man after spinal cord injury. outflow to muscle below the lesion. Brain 1986;109(Pt 4):695–715.
   PubMed Web of Science ®Google Scholar
• Monroe MB, Tataranni PA, Pratley R, Manore MM, Skinner JS, Ravussin E. Lower daily energy expenditure as measured by a respiratory chamber in subjects with spinal cord injury compared with control subjects. Am J Clin Nutr 1998;68(6):1223–27.
   PubMed Web of Science ®Google Scholar
• Bauman WA, Spungen AM, Wang J, Pierson Jr RN. The relationship between energy expenditure and lean tissue in monozygotic twins discordant for spinal cord injury. J Rehabil Res Dev 2004;41(1):1–8.
   PubMedGoogle Scholar
• Buchholz AC, Pencharz PB. Energy expenditure in chronic spinal cord injury. Curr Opin Clin Nutr Metab Care 2004;7(6):635–39.
   PubMed Web of Science ®Google Scholar
• Maki K, Briones E, Langbein W, Inman-Felton A, Nemchausky B, Welch M, et al. Associations between serum lipids and indicators of adiposity in men with spinal cord injury. Paraplegia 1995;33(2):102–09.
   PubMedGoogle Scholar
• Edwards LA, Bugaresti JM, Buchholz AC. Visceral adipose tissue and the ratio of visceral to subcutaneous adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist circumferences. Am J Clin Nutr 2008;87(3):600–07.
   PubMed Web of Science ®Google Scholar
• Jones LM, Legge M, Goulding A. Healthy body mass index values often underestimate body fat in men with spinal cord injury. Arch Phys Med Rehabil 2003;84(7):1068–71.
   PubMed Web of Science ®Google Scholar
• George C, Wells C, Dugan N. Validity of hydrodensitometry for determination of body composition in spinal injured subjects. Hum Bio 1988;60(5):771–80.
   PubMed Web of Science ®Google Scholar
• Crane DA, Little JW, Burns SP. Weight gain following spinal cord injury: a pilot study. J Spinal Cord Med 2011;34(2):227–32.
   PubMed Web of Science ®Google Scholar
• Boninger ML, Dicianno BE, Cooper RA, Towers JD, Koontz AM, Souza AL. Shoulder magnetic resonance imaging abnormalities, wheelchair propulsion, and gender. Arch Phys Med Rehabil 2003;84(11):1615–20.
   PubMed Web of Science ®Google Scholar
• Ballinger DA, Rintala DH, Hart KA. The relation of shoulder pain and range-of-motion problems to functional limitations, disability, and perceived health of men with spinal cord injury: a multifaceted longitudinal study. Arch Phys Med Rehabil 2000;81(12):1575–81.
   PubMed Web of Science ®Google Scholar
• Gellman H, Sib I, Waters RL. Late complications of the weight-bearing upper extremity in the paraplegic patient. Clin Orthop Relat R 1988;233:132–35.
   PubMed Web of Science ®Google Scholar
• Cardinal BJ, Kosma M, McCubbin JA. Factors influencing the exercise behavior of adults with physical disabilities. Med Sci Sport Exer 2004;36(5):868–75.
   PubMed Web of Science ®Google Scholar
• Kehn M, Kroll T. Staying physically active after spinal cord injury: a qualitative exploration of barriers and facilitators to exercise participation. BMC Public Health 2009;9:168.
   PubMed Web of Science ®Google Scholar
• The Diabetes Prevention Program (DPP). Description of lifestyle intervention. Diabetes Care 2002;25(12):2165–71.
   PubMed Web of Science ®Google Scholar
• The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999;22(4):623–34.
   PubMed Web of Science ®Google Scholar
• Steinberg D, Bennett GG, Svetkey L. The DASH diet, 20 years later. J Am Med Assoc 2017;317(15):1529–30.
   Web of Science ®Google Scholar
• Banerjea R, Sambamoorthi U, Weaver F, Maney M, Pogach LM, Findley T. Risk of stroke, heart attack, and diabetes complications among veterans with spinal cord injury. Arch Phys Med Rehabil 2008;89(8):1448–53.
   PubMed Web of Science ®Google Scholar
• Anson C, Shepherd C. Incidence of secondary complications in spinal cord injury. Int J Rehabil Res 1996;19(1):55–66.
   PubMed Web of Science ®Google Scholar
• Yekutiel M, Brooks M, Ohry A, Yarom J, Carel R. The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees. Spinal Cord 1989;27(1):58–62.
   Web of Science ®Google Scholar
• Bauman WA, Zhong YG, Schwartz E. Vitamin D deficiency in veterans with chronic spinal cord injury. Metabolism 1995;44(12):1612–16.
   PubMed Web of Science ®Google Scholar
• McKinley WO, Jackson AB, Cardenas DD, DeVivo MJ. Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch Phys Med Rehabil 1999;80(11):1402–10.
   PubMed Web of Science ®Google Scholar
• Nemunaitis GA, Mejia M, Nagy JA, Johnson T, Chae J, Roach MJ. A descriptive study on vitamin D levels in individuals with spinal cord injury in an acute inpatient rehabilitation setting. PM R 2010;2(3):202–08.
   PubMedGoogle Scholar
• Barber D, Foster D, Rogers S. The importance of nutrition in the care of persons with spinal cord injury. J Spinal Cord Med 2003;26(2):122–23.
   PubMed Web of Science ®Google Scholar
• Alexander LR, Spungen AM, Liu MH, Losada M, Bauman WA. Resting metabolic rate in subjects with paraplegia: the effect of pressure sores. Arch Phys Med Rehabil 1995;76(9):819–22.
   PubMed Web of Science ®Google Scholar
• Levine AM, Nash MS, Green BA, Shea JD, Aronica MJ. An examination of dietary intakes and nutritional status of chronic healthy spinal cord injured individuals. Paraplegia 1992;30(12):880–89.
   PubMedGoogle Scholar
• Peiffer SC, Blust P, Leyson JF. Nutritional assessment of the spinal cord injured patient. J Am Diet Assoc 1981;78(5):501–05.
   PubMedGoogle Scholar
• Chen Y, Henson S, Jackson A, Richards J. Obesity intervention in persons with spinal cord injury. Spinal Cord 2006;44(2):82–91.
   PubMed Web of Science ®Google Scholar
• Weinsier R, Bacon J, Birch R. Time-calorie displacement diet for weight control: a prospective evaluation of its adequacy for maintaining normal nutritional status. Int J Obes 1982;7(6):539–48.
   Web of Science ®Google Scholar
• Cowan RE, Nash MS, Anderson-Erisman K. Perceived exercise barriers and odds of exercise participation among persons with SCI living in high- income households. Top Spinal Cord Inj Rehabil 2012;18(2):126–27.
   PubMedGoogle Scholar
• Jacobs PL, Nash MS, Rusinowski JW. Circuit training provides cardiorespiratory and strength benefits in persons with paraplegia. Med Sci Sports Exerc 2001;33(5):711–17.
   PubMed Web of Science ®Google Scholar
• Nash MS, van de Ven I, van Elk N, Johnson BM. Effects of circuit resistance training on fitness attributes and upper-extremity pain in middle- aged men with paraplegia. Arch Phys Med Rehabil 2007;88(1):70–5.
   PubMed Web of Science ®Google Scholar
• Hicks A, Ginis KM, Pelletier C, Ditor D, Foulon B, Wolfe D. The effects of exercise training on physical capacity, strength, body composition and functional performance among adults with spinal cord injury: a systematic review. Spinal Cord 2011;49(11):1103–27.
   PubMed Web of Science ®Google Scholar
• Nash M. Exercise reconditioning of the heart and peripheral circulation after spinal cord injury. Top Spinal Cord Inj Rehabil 1998;3:1–15.
   Google Scholar
• Cowan RE, Nash MS. Cardiovascular disease, SCI and exercise: unique risks and focused countermeasures. Disabil Rehabil 2010;32(26):2228–36.
   PubMed Web of Science ®Google Scholar
• Cowan RE, Malone LA, Nash MS. Exercise is medicine™: exercise prescription after SCI to manage cardiovascular disease risk factors. Top Spinal Cord Inj Rehabil 2009;14(3):69–83.
   Google Scholar
• Nash MS, Cowan RE. Cardiovascular disease, SCI and exercise: unique risks and focused countermeasures. Vol 32. 2010/06/08 ed2010.
   Google Scholar
• Pedersen BK, Saltin B. Exercise as medicine– evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports 2015;25(S3):1–72.
   PubMed Web of Science ®Google Scholar
• American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2018.
   Google Scholar
• Vetter ML, Faulconbridge LF, Webb VL, Wadden TA. Behavioral and pharmacologic therapies for obesity. Nat Rev Endocrinol 2010;6(10):578–88.
   PubMed Web of Science ®Google Scholar
• Rossner S, Sjostrom L, Noack R, Meinders E, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res 2000;8(1):49–61.
   PubMedGoogle Scholar
• Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. Xenical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care 2004;27(1):155–61.
   PubMed Web of Science ®Google Scholar
• Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf 2006;29(4):277–302.
   PubMed Web of Science ®Google Scholar
• Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 2007;335(7631):1194–99.
   PubMed Web of Science ®Google Scholar
• Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. The Am J Clin Nutr 2012;95(2):297–308.
   PubMed Web of Science ®Google Scholar
• Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, et al. Controlled- release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity 2012;20(2):330–42.
   PubMed Web of Science ®Google Scholar
• Rothman RB, Hendricks EJ. Phentermine cardiovascular safety. Am J Emerg Med 2009;27(8):1010–13.
   PubMed Web of Science ®Google Scholar
• Kang J, Park CY, Kang J, Park YW, Park S. Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse- controlled release for obesity. Diabetes Obes Metab 2010;12(10):876–82.
   PubMed Web of Science ®Google Scholar
• Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet 2010;376(9741):595–605.
   PubMed Web of Science ®Google Scholar
• Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O’Neil PM, et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity 2011;19(1):110–20.
   PubMed Web of Science ®Google Scholar
• Gustafson A, King C, Rey JA. Lorcaserin (Belviq): A selective serotonin 5-HT2C agonist in the treatment of obesity. Pharmacy and Therapeutics 2013;38(9):525–34.
   Google Scholar
• Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm–2016 executive summary. Endocr Pract 2016;22(1):84–113.
   PubMed Web of Science ®Google Scholar
• Chamberlain JJ, Herman WH, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, et al. Pharmacologic therapy for type 2 diabetes: synopsis of the 2017 American diabetes association standards of medical care in diabetes pharmacologic therapy for type 2 diabetes. Ann Intern Med 2017;166(8):572–78.
   PubMed Web of Science ®Google Scholar
• Finnie A, Buchholz A, Ginis KM. Current coronary heart disease risk assessment tools may underestimate risk in community-dwelling persons with chronic spinal cord injury. Spinal Cord 2008;46(9):608–15.
   PubMed Web of Science ®Google Scholar
• Ellenbroek D, Kressler J, Cowan RE, Burns PA, Mendez AJ, Nash MS. Effects of prandial challenge on triglyceridemia, glycemia, and pro-inflammatory activity in persons with chronic paraplegia. J Spinal Cord Med 2015;38(4):468–75.
   PubMed Web of Science ®Google Scholar
• Nash MS, DeGroot J, Martinez-Arizala A, Mendez AJ. Evidence for an exaggerated postprandial lipemia in chronic paraplegia. J Spinal Cord Med 2005;28(4):320–25.
   PubMed Web of Science ®Google Scholar
• Chopra AS, Miyatani M, Craven BC. Cardiovascular disease risk in individuals with chronic spinal cord injury: prevalence of untreated risk factors and poor adherence to treatment guidelines. J Spinal Cord Med 2018;41(1):2–9.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Hammond FM, Barringer TA, Norton HJ, Goff DC, Bockenek WL, et al. Comparison of coronary artery calcification scores and national cholesterol education program guidelines for coronary heart disease risk assessment and treatment paradigms in individuals with chronic traumatic spinal cord injury. J Spinal Cord Med 2011;34(2):233–40.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Hammond FM, Barringer TA, Goff DC, Norton HJ, Bockenek WL, et al. Adherence with the national cholesterol education program guidelines in men with chronic spinal cord injury. J Spinal Cord Med 2011;34(1):28–34.
   PubMed Web of Science ®Google Scholar
• Nash MS, Jacobs PL, Mendez AJ, Goldberg RB. Circuit resisitance training improves the atherogenic lipid profile in persons with chronic paraplegia. J Spinal Cord Med 2001;24(1):2–9.
   PubMedGoogle Scholar
• Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New Engl J Med 2016;374(21):2021–31.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Danielson E, Fonseca F, Genest J, Gotto AM, Kastelein JJP, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New Engl J Med 2008;359(21):2195–207.
   PubMed Web of Science ®Google Scholar
• Stillman M, Aston C, Rabadi M. Mortality benefit of statin use in traumatic spinal cord injury: a retrospective analysis. Spinal Cord 2016;54(4):298–302.
   PubMed Web of Science ®Google Scholar
• Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, et al. Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch Phys Med Rehabil 2011;92(3):399–410.
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence- based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). J Am Med Assoc 2014;311(5):507–20.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American college of physicians and the American academy of family physicians, pharmacologic treatment of hypertension in adults. Ann Intern Med 2017;166(6):430–37.
   PubMed Web of Science ®Google Scholar
• Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community. J Clin Hypertens 2014;16(1):14–26.
   PubMed Web of Science ®Google Scholar
• Go AS, Bauman MA, King SMC, Fonarow GC, Lawrence W, Williams KA, et al. An effective approach to high blood pressure control. Hypertension 2014;63(4):878–85.
   PubMed Web of Science ®Google Scholar
• Alaedeen DI, Jasper J. Gastric bypass surgery in a paraplegic morbidly obese patient. Obes Surg 2006;16(8):1107–08.
   PubMed Web of Science ®Google Scholar
• Williams GJ, Georgiou PA, Cocker DM, Bonanomi G, Smellie J, Efthimiou E. The safety and efficacy of bariatric surgery for obese wheelchair-bound patients. Ann R Coll Surg Engl 2014;96(5):373–76.
   PubMed Web of Science ®Google Scholar
• Wong S, Barnes T, Coggrave M, Forbes A, Pounds-Cornish E, Appleton S, et al. Morbid obesity after spinal cord injury: an ailment not to be treated? Eur J Clin Nutr 2013;67(9):998–99.
   PubMed Web of Science ®Google Scholar
• Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres A, Weiner R, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg 2014;24(1):42–55.
   PubMed Web of Science ®Google Scholar
• Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American association of clinical endocrinologists, The obesity society, and American society for metabolic & bariatric surgery. Obesity 2013;21:S1–S27.
   PubMed Web of Science ®Google Scholar
• Aminian A, Andalib A, Khorgami Z, Cetin D, Burguera B, Bartholomew J, et al. Who should Get extended thromboprophylaxis after bariatric surgery? A risk assessment tool to guide indications for post-discharge pharmacoprophylaxis. Ann Surg 2017;265(1):143–50.
   PubMed Web of Science ®Google Scholar